Immunoclin Corp Finite-lived Intangible Assets, Fair Value Disclosure
Immunoclin Corp had Finite-lived Intangible Assets, Fair Value Disclosure of $19.41 million as of 2014-04-30, per its 10-Q filed 2014-07-24.
Discontinued › Notes
us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure · last filed 2014-07-24
- 2014-04-30: Finite-lived Intangible Assets, Fair Value Disclosure $19.41M.
- 2014-01-31: Finite-lived Intangible Assets, Fair Value Disclosure $19.79M.
| Period end | Finite-lived Intangible Assets, Fair Value Disclosure |
|---|---|
| 2014-04-30 | $19.41M 10-Q · filed 2014-07-24 |
| 2014-01-31 | $19.79M 10-Q · filed 2014-07-24 |